cv impact/trt

Key issues • The use of testosterone therapy (TTh) for late onset hypogonadism has been questioned due to possible increased cardiovascular risk. • Food and Drug Administration Drug Administration (FDA) in its final release approved TTh only for men with “classical hypogonadism”, i.e. due to...